Sargent Bickham Lagudis’s BCE BCE Stock Holding History

Sargent Bickham Lagudis’s Portfolio BCE Stock Details BCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-102	Closed	-$5K	–	776
2019 Q4	$5K	Buy	+102	New	+$4.88K	﹤0.01%	682
2016 Q4	–	Sell	-542	Closed	-$25	–	711
2016 Q3	$25	Buy	+542	New	+$25.7K	﹤0.01%	448

Other funds holding BCE

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Sargent Bickham Lagudis's BCE Position: Q1 2020 in Review

Sargent Bickham Lagudis sold out of BCE (BCE) in Q1 2020, closing a stake of 102 shares — an estimated $5K sold.

Sargent Bickham Lagudis first reported a position in BCE in Q3 2016 and held it in 2 quarters. The position peaked at $5K in Q4 2019. 514 funds tracked by Wall St. Rank hold BCE as of Q1 2020.

Sargent Bickham Lagudis reported no remaining BCE position as of Q1 2020 after selling out during the quarter.
Sargent Bickham Lagudis sold 102 BCE shares in Q1 2020, an estimated $5K.
Sargent Bickham Lagudis first reported a position in BCE in Q3 2016 and held it in 2 quarters.
Sargent Bickham Lagudis's BCE position peaked at $5K in Q4 2019.
514 funds tracked by Wall St. Rank held BCE as of Q1 2020.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2020, filed 7 Sep 2021.